Experts are eagerly anticipating pozelimab, a experimental treatment showing encouraging results in preliminary clinical trials . This medication targets tau protein – a significant hallmark of https://opensocialfactory.com/story26552118/pozelimab-a-new-breakthrough-for-alzheimer-s